Literature DB >> 11786310

Chemokines in the brain: neuroimmunology and beyond.

Knut Biber1, Mike W Zuurman, Inneke M Dijkstra, Hendrikus W G M Boddeke.   

Abstract

Chemokines in the brain have been recognised as essential elements in neurodegenerative diseases and related neuroinflammation. Recent studies suggest that in addition to the orchestration of chemotaxis of immune cells, chemokines are also involved in neurodevelopment and neurophysiological signalling.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11786310     DOI： 10.1016/s1471-4892(01)00122-9

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN： 1471-4892            Impact factor:   5.547


  24 in total

Review 1.  Chemokines and glial cells: a complex network in the central nervous system.

Authors:  Elena Ambrosini; Francesca Aloisi
Journal:  Neurochem Res       Date:  2004-05       Impact factor: 3.996

Review 2.  Human cellular inflammation in the pathology of acute cerebral ischaemia.

Authors:  C J S Price; E A Warburton; D K Menon
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-11       Impact factor: 10.154

Review 3.  Inflammatory cell trafficking across the blood-brain barrier: chemokine regulation and in vitro models.

Authors:  Yukio Takeshita; Richard M Ransohoff
Journal:  Immunol Rev       Date:  2012-07       Impact factor: 12.988

Review 4.  Microglia.

Authors:  Denise van Rossum; Uwe-Karsten Hanisch
Journal:  Metab Brain Dis       Date:  2004-12       Impact factor: 3.584

Review 5.  The role of glial adenosine receptors in neural resilience and the neurobiology of mood disorders.

Authors:  Dietrich van Calker; Knut Biber
Journal:  Neurochem Res       Date:  2005-10       Impact factor: 3.996

6.  Proteolytic processing of SDF-1alpha reveals a change in receptor specificity mediating HIV-associated neurodegeneration.

Authors:  David Vergote; Georgina S Butler; Martine Ooms; Jennifer H Cox; Claudia Silva; Morley D Hollenberg; Jack H Jhamandas; Christopher M Overall; Christopher Power
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-05       Impact factor: 11.205

7.  Anti-inflammatory and immunomodulatory effects of RDV-8 [C18H22N2O2S (ethyl 1-butyl-6-methyl-2-phenyl-4-thioxo-1,4-dihydropyrimidine-5-carboxylate)] in a rat model of induced pleurisy and in vitro lymphoproliferation.

Authors:  Marcos Schuch Azambuja; Adroaldo Lunardelli; Robson Henrich Amaral; Fernanda Bordignon Nunes; Eduardo Caberlon; Vinicius Lorini da Costa; Márcio Vinícius Fagundes Donadio; Daniela Nunes Vitor; Alberto da Silva Melo Denizar; Silvio Cunha; Jarbas Rodrigues de Oliveira
Journal:  Inflammopharmacology       Date:  2010-10-28       Impact factor: 4.473

8.  Perturbation of chemokine networks by gene deletion alters the reinforcing actions of ethanol.

Authors:  Yuri A Blednov; Susan E Bergeson; Danielle Walker; Vania M M Ferreira; William A Kuziel; R Adron Harris
Journal:  Behav Brain Res       Date:  2005-08-18       Impact factor: 3.332

9.  Polarization of the yeast pheromone receptor requires its internalization but not actin-dependent secretion.

Authors:  Dmitry V Suchkov; Reagan DeFlorio; Edward Draper; Amber Ismael; Madhushalini Sukumar; Robert Arkowitz; David E Stone
Journal:  Mol Biol Cell       Date:  2010-03-24       Impact factor: 4.138

10.  Role of astrocytes and chemokine systems in acute TNFalpha induced demyelinating syndrome: CCR2-dependent signals promote astrocyte activation and survival via NF-kappaB and Akt.

Authors:  Marlon P Quinones; Yogeshwar Kalkonde; Carlos A Estrada; Fabio Jimenez; Robert Ramirez; Lenin Mahimainathan; Srinivas Mummidi; Goutam G Choudhury; Hernan Martinez; Lisa Adams; Matthias Mack; Robert L Reddick; Shivani Maffi; Sylva Haralambous; Lesley Probert; Sunil K Ahuja; Seema S Ahuja
Journal:  Mol Cell Neurosci       Date:  2007-09-14       Impact factor: 4.314
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.